Skip to navigation Site map About Us Careers Contact DISCOVaerie™ Live! SEARCH PRODUCTS R&D INVESTORS ABOUT US Our Scientific Heritage Aerie At-a-Glance Our Leadership Our Board of Directors Our ESG Commitment Inspiration. Imagination. Innovation. Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. We have a passion for finding new approaches for protecting or improving vision. United by VISIONaerie® Science, deep clinical insights, and a singular focus on addressing the unmet needs in ophthalmology, we see the possibilities ahead. Join us in creating the future of eye care. OUR SCIENTIFIC HERITAGE From an idea that started at Duke University, we have built a company committed to innovation in eye care. MORE OUR LEADERSHIP Meet the eye care VISIONaerieS® building the next major ophthalmic pharmaceutical company. MORE OUR BOARD OF DIRECTORS In our pursuit of scientific, clinical, and operational excellence, we are guided by some of the best minds in the healthcare industry. MORE PRODUCTS Overview Rhopressa® Rocklatan® DISCOVaerie™ Live! R&D Pipeline Glaucoma Ocular Surface Disease - AR-15512 Retinal Disease - AR-1105 Implant - AR-13503 SR Implant - AR-14034 SR Implant Clinical Trials Research Bibliography Investigator Initiated Research Medical Affairs INVESTORS FAQs News & Presentations Stock Information Reports & Filings Corporate Governance Our Leadership Our Board of Directors Contact Us ABOUT US Our Scientific Heritage Aerie At-a-Glance Our Leadership Our Board of Directors Our ESG Commitment CAREERS CONTACT General Inquiries Corporate Headquarters 4301 Emperor Blvd Suite 400 Durham, NC 27703 Tel. +1 919-237-5300 AERIE PHARMACEUTICALS, INC. ©2021 All Rights Reserved. This site intended for U.S. audiences only. Terms of Use Privacy Policy California Residents